Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001571192 | SCV001795615 | uncertain significance | not provided | 2020-11-02 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001571192 | SCV003291484 | likely benign | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039369 | SCV004918409 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.2471T>C (p.I824T) alteration is located in exon 18 (coding exon 18) of the AARS2 gene. This alteration results from a T to C substitution at nucleotide position 2471, causing the isoleucine (I) at amino acid position 824 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |